CAT
Caterpillar Inc.
CAT has lower modeled downside risk, despite its lower overall score.
RFIL
RF Industries, Ltd.
RFIL has a slight edge over CAT overall, supported by stronger valuation.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
RFIL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
RFIL's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over RFIL in the historical PE scenario, which offers more potential upside but is not a forecast.
RFIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.9x | $7.63 | — |
| Cheap | 14x | $2.95 | -61% |
| Fair | 32x | $6.68 | -12% |
| Current | 36x | $7.63 | — |
| Expensive | 109x | $22.86 | +200% |
Historical ranges are pointers, not guarantees.
RFIL's PE is in its fair range at 36x. If earnings grow as analysts expect, today's price would be 9.9x next year's earnings, in its cheap range.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
RFIL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for RFIL, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
RFIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.77 | +267% |
| Q3 2026 | $0.21 | +$0.23 |
| Q2 2026 | $0.13 | +$0.26 |
| Q1 2026 | $0.03 | +$0.55 |
| Q4 2025 | $0.01 | +$0.64 |
| Q3 2025 | -$0.02 | +$0.68 |
| Q2 2025 | -$0.13 | +$0.66 |
| Q1 2025 | -$0.52 | -$0.20 |
| Q4 2024 | -$0.63 | -$0.33 |
RFIL has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over RFIL on profitability, with a higher operating margin.
RFIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24M | +21% |
| Q2 2026 | $20.7M | +9.4% |
| Q1 2026 | $19M | -1.2% |
| Q4 2025 | $22.7M | +23% |
| Q3 2025 | $19.8M | +18% |
| Q2 2025 | $18.9M | +17% |
| Q1 2025 | $19.2M | +43% |
| Q4 2024 | $18.5M | +16% |
RFIL has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.3% | +3.7 points |
| Q2 2026 | 5.3% | +4.8 points |
| Q1 2026 | 0.9% | +0.6 points |
| Q4 2025 | 4% | +3.5 points |
| Q3 2025 | 3.6% | +6.1 points |
| Q2 2025 | 0.6% | +3.1 points |
| Q1 2025 | 0.3% | +16 points |
| Q4 2024 | 0.5% | +7.5 points |
RFIL's operating margin was 7.3% last quarter, up 3.7 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
RFIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5M | +$1.9M |
| Q2 2026 | -$946K | -144% |
| Q1 2026 | $649K | +13% |
| Q4 2025 | $2M | +$2.5M |
| Q3 2025 | -$419K | -120% |
| Q2 2025 | $2.2M | +7604% |
| Q1 2025 | $574K | -18% |
| Q4 2024 | -$418K | -129% |
RFIL generated $3M in free cash flow over the past year, up 70% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over RFIL on leverage, with a lower net debt burden relative to earnings.
RFIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 3.7x | Elevated |
| Q3 2023 | 27.3x | High |
RFIL's net debt is less than a year of its operating earnings (EBITDA), down from 1.4 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RFIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 11.4 | Oversold |
RFIL's weekly RSI is 39 (neutral) and its Stochastic is 11 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over RFIL on valuation relative to its sector.
RFIL PE vs Industrials Sector
| Metric | RFIL | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 24x | 51% above |
| PE % | 59 | 58 | 1 pt above |
RFIL is trading at 36x earnings, a 51% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
RFIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.61 | 0.3% above |
| 20 week MA | $10.5 | 28% below |
| 50 week MA | $11.4 | 33% below |
| 100 week MA | $8.53 | 11% below |
| 200 week MA | $6.12 | 25% above |
RFIL's trend is mixed: it's above two of its five weekly moving averages, and 25% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
RFIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.71 | $4.95 | -26% |
| 2021 | $4.95 | $7.42 | +50% |
| 2022 | $7.42 | $5.15 | -31% |
| 2023 | $5.15 | $3.04 | -41% |
| 2024 | $3.04 | $3.83 | +26% |
| 2025 | $3.83 | $5.98 | +56% |
| 2026 YTD | $5.98 | $7.63 | +28% |
RFIL has the edge over CAT on returns for 2026, with the stronger performance.